Chemoinformaics analysis of 3-O-acetylaleuritolate acid
| Molecular Weight | 498.748 | nRot | 2 |
| Heavy Atom Molecular Weight | 448.348 | nRig | 28 |
| Exact Molecular Weight | 498.371 | nRing | 5 |
| Solubility: LogS | -5.049 | nHRing | 0 |
| Solubility: LogP | 6.495 | No. of Aliphatic Rings | 5 |
| Acid Count | 1 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 5 |
| Atoms Count | 86 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 36 | No. of Aromatic Carbocycles | 0 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 4 |
| No. of Hydrogen atom | 50 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 32 | No. of Saturated Rings | 4 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 0 |
| nHA | 3 | APOL | 89.9876 |
| nHD | 1 | BPOL | 53.6324 |
| QED | 0.311 |
| Synth | 4.855 |
| Natural Product Likeliness | 2.906 |
| NR-PPAR-gamma | 0.965 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.001 |
| Pgp-sub | 0 |
| HIA | 0.018 |
| CACO-2 | -5.1 |
| MDCK | 0.0000141 |
| BBB | 0.186 |
| PPB | 0.982309 |
| VDSS | 0.759 |
| FU | 0.0238589 |
| CYP1A2-inh | 0.003 |
| CYP1A2-sub | 0.313 |
| CYP2c19-inh | 0.021 |
| CYP2c19-sub | 0.933 |
| CYP2c9-inh | 0.096 |
| CYP2c9-sub | 0.86 |
| CYP2d6-inh | 0.006 |
| CYP2d6-sub | 0.189 |
| CYP3a4-inh | 0.108 |
| CYP3a4-sub | 0.192 |
| CL | 1.878 |
| T12 | 0.019 |
| hERG | 0 |
| Ames | 0.02 |
| ROA | 0.038 |
| SkinSen | 0.012 |
| Carcinogencity | 0.031 |
| EI | 0.788 |
| Respiratory | 0.953 |
| NR-Aromatase | 0.878 |
| Antiviral | Yes |
| Prediction | 0.708326 |